9.12.2022 12:58:26 CET | Demant A/S |
Finanskalender
Selskabsmeddelelse nr. 2022-14
9. december 2022
Finanskalender for 2023
24. januar
Frist for indlevering af emner til dagsordenen for den ordinære generalforsamling*
17. januar til 6. februar
Stilleperiode forud for offentliggørelse af Årsrapport 2022
7. februar
Årsrapport 2022
8. marts
Ordinær generalforsamling
12. april til 2. maj
Stilleperiode forud for offentliggørelse af periodemeddelelse
3. maj
Periodemeddelelse
26. juli til 15. august
Stilleperiode forud for offentliggørelse af Halvårsrapport 2023
16. august
Halvårsrapport 2023
17. oktober til 6. november
Stilleperiode forud for offentliggørelse af periodemeddelelse
7. november
Periodemeddelelse
* Såfremt en aktionær ønsker et bestemt emne behandlet på den ordinære generalforsamling den 8. marts 2023, skal begæring herom indsendes skriftligt til bestyrelsen senest seks uger inden afholdelse af generalforsamlingen, således at begæringen er bestyrelsen i hænde senest den 24. januar 2023.
Yderligere information:
Peter Pudselykke, Investor Relations Officer
Telefon +45 3917 7300
www.demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2022-14 Finanskalender 2023.pdf
9.12.2022 12:58:26 CET | Demant A/S |
Financial Calendar
Company announcement no 2022-14
9 December 2022
Financial calendar 2023
24 January
Deadline for submission of items for the agenda of the annual general meeting*
17 January to 6 February
Quiet period prior to publication of Annual Report 2022
7 February
Annual Report 2022
8 March
Annual general meeting
12 April to 2 May
Quiet period prior to publication of Interim Management Statement
3 May
Interim Management Statement
26 July to 15 August
Quiet period prior to publication of Interim Report 2023
16 August
Interim Report 2023
17 October to 6 November
Quiet period prior to publication of Interim Management Statement
7 November
Interim Management Statement
* Please note that if a shareholder would like to have a specific item included in the agenda for the annual general meeting on 8 March 2023, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 24 January 2023.
Further information:
Peter Pudselykke, Investor Relations Officer
Phone +45 3917 7300
www.demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2022-14 Financial calendar 2023.pdf
